About us
Nanox is a nano-biotechnology company, constantly engaged in the research and development of advanced discovery, testing and commercialization of nano-pharmaceutical drugs.
We are an R&D based company gathering several years of expertise in the development, managing, filing and commercialization of nano and modified release medicines.
Liposomes, PEGylated Liposomes, microfluidic, intramuscular polymer implants, PLGA microspheres and nanoparticles are some of the technologies that we have experience with.
These technologies can enhance biodistribution, toxicity profile and drug substance stability and these characteristics have been applied to cancer, antibiotic and inflammatory treatment.
Our core business comprises the development of manufacturing processes of complex generics along with technical support during registration of these formulations. We have experience in several territories, including some of the most demanding regulatory agencies.
Management & R&D technical team expertise
Senior team with great experience in development of controlled release technologies and targeted therapies. We have stablished collaboration agreements with most important R&D centers in bio and nanotechnology from Argentina and ROW.
Our success is to connect scientific experts in the nanotechnology field with our commitment, passion and creativity to bring innovation to the patient needs.
Why nanox?
Manufacturing
Nanox holds several manufacturing equipment/areas in an R&D environment for production of material for both non-clinical and clinical studies.
Nanox also manages manufacturing areas at third-party sites for manufacturing of both injectable complex oncologic or hormonal formulations as well as general purpose formulations.